SIGN IN
Remember Me
Forgot Password?
Advanced Search >>
By Topic:
> Atherosclerosis/CVD
> Dyslipidemia
> Inflammation/Pleiotropic Effects
> Metabolic Syndrome
> Therapeutic Interventions
News:
> Lipid Management
> General Cardiology
> Conference Highlights
Continuing Education:
> Newsletters
> Webcasts
> Interactive Cases
> How to Get CE Credit
Expert Content:
> Editorials
> Q & A
Resources & Tools:
> Slide Library
> Animation Library
> Clinical Tools
> Related Links
Events:
> Upcoming
Mulberry leaves inhibit ox-LDL receptor expression
Tuesday, October 24, 2006 - Aqueous extracts from mulberry leaves inhibit the expression of a receptor involved in inflammation and endothelial dysfunction, say Japanese scientists.
Glucosamine treatment not linked to long-term atherosclerosis
Monday, October 23, 2006 - Contrary to previous anecdotal reports, taking the nutritional supplement glucosamine to treat osteoathrisitis does not have long-term adverse vascular consequences, say US scientists.
CETP enhances atherosclerosis in mice
Monday, October 23, 2006 - Scientists have created a mouse model that demonstrates the pro-atherogenic role of cholesteryl ester transfer protein.
No news available
Interview with Dr. Michael Davidson at EASD: Implications of PROactive
Michael H. Davidson, MD, FACC, FACP
Athens, Greece. The results from the landmark Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive) were presented at the 41st meeting of the European Association for the Study of Diabetes (EASD) 2005.
Pathophysiology of Atherosclerosis
Activity Type:
CE Slide Presentation
© Copyright 2008 CVspectrum.org.
About CVspectrum
|
Terms of Use
|
Privacy Policy
|
Site Map
|
Contact Us
Supported by educational grants from Abbott Laboratories, AstraZeneca Pharmaceuticals LP and Takeda Pharmaceuticals North America, Inc.
